Clinical Trials › NCT04458688
Recruiting
Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
Sponsored by Wayne State University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 80
Target enrollment
1
U.S. states
Nov 2021
Start date
Dec 2030
Expected completion
Interventions / Treatments
Observation of Ocrelizumab as Treatment in RRMS Patients
Conditions studied
Multiple Sclerosis, Relapsing-Remitting
Where this trial is running (1 site)
Michigan1 site
Detroit
Participating MS centers on MS Buddy (1)
MS centers in Michigan
Compare treatment centers near a trial site by center type, providers and trials.
View Michigan centersThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.